Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells
Authors:
- Eugenio GalliEGEugenio Galli
- Federica SoràFSFederica Sorà
- Stefan HohausSHStefan Hohaus
- Alberto FresaAFAlberto Fresa
- Francesco AutoreFAFrancesco Autore
- Elisabetta MetafuniEMElisabetta Metafuni
- Idanna InnocentiIIIdanna Innocenti
- Maria Assunta LimongielloMLMaria Assunta Limongiello
- Sabrina GiammarcoSGSabrina Giammarco
- Luca LaurentiLLLuca Laurenti
- Andrea BacigalupoABAndrea Bacigalupo
Open Access
- 11 December 2022
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 201 (1) , 86-94
Abstract
Summary: Cytokine release syndrome (CRS) and consumptive coagulopathy can complicate the treatment with chimeric antigen receptor T (CAR‐T) cells. The modified version of the Endothelial Activation and Stress Index (mEASIX), a score derived from haematopoietic stem cell transplantation, combines platelets, C‐reactive protein (CRP), and lactate dehydrogenase (LDH) and has been correlated with CRS and endothelial biomarkers. In 38 consecutive patients with aggressive lymphoproliferative disease we measured a coagulative laboratory panel at baseline and early after infusion of anti‐CD19 CAR‐T. The panel was investigated also in the presence of CRS graded 2 or higher, or immune effector cell‐associated neurotoxicity syndrome (ICANS). Moreover, we examined the relationship between mEASIX, coagulation biomarkers, and toxicities of CAR‐T cells. During CRS grade 2 or higher, we found increased prothrombin time (PT) and activated partial thromboplastin time (aPTT), fibrinogen, D‐dimer, factor VIII (FVIII), and von Willebrand factor (vWF) antigen levels, and decreased platelet count and antithrombin levels. The occurrence of immune effector cell‐associated neurotoxicity syndrome was associated with higher PT values, D‐dimer, FVIII, and vWF levels, and decreased fibrinogen levels and platelet count. A higher mEASIX score correlated with increased aPTT values, fibrinogen, D‐dimer, FVIII and vWF levels, and decreased antithrombin levels. Baseline mEASIX was predictive for consumptive coagulopathy and CRS graded 2 or higher, and for progression‐free survival and overall survival.Keywords
This publication has 29 references indexed in Scilit:
- Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathyAnnals of Hematology, 2019
- ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsTransplantation and Cellular Therapy, 2019
- Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cellsCell Communication and Signaling, 2018
- Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic LeukemiaCancer Discovery, 2018
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T CellsCancer Discovery, 2017
- Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapyBlood, 2017
- EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysisThe Lancet Haematology, 2017
- The ST2/IL-33 Axis in Immune Cells during Inflammatory DiseasesFrontiers in Immunology, 2017
- Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and HemostasisThrombosis Journal, 2016
- Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular CoagulationThrombosis and Haemostasis, 2001